Mindprint Inc. and ethica Clinical Research Inc. announced the successful implementation of a highly effective Enterprise Resource Planning (ERP) system for managing all pre-sales, operations, and finance related processes for ethica Clinical Research Inc. ethica Clinical Research Inc. is a full-service Contract Research Organization (CRO) operating in Canada, Mexico and India that conducts and manages ethical clinical research on drugs, biologics, medical devices, and natural health products. ethica had evaluated multiple ERP systems and found that none fully met their requirements. All of the standard ERP systems either did not have the functionality needed to meet ethica's requirements or were so rigid that ethica would have had to change their internal processes to suit the software.
ethica originally engaged Mindprint for a two-week requirement gathering session that began with an assessment and exploration of ethica's internal work processes and resulted in the generation of the ideal processes for an ERP system that would fit ethica's size and culture. Mindprint then provided a fixed price quote for mapping all of ethica's work processes including customer relationship management, human resources, operations, timesheets, and invoicing into an Axpert based ERP system.
The entire ERP system implementation within ethica's organization (including design, development, installation, and data migration) was done in less than four months. Mindprint's iterative approach ensured that the key users at ethica were highly engaged during the entire implementation process and this resulted in a system that fit ethica like a glove. Mindprint's fixed price approach also significantly mitigated the financial risk of the project for ethica's senior management.
"Mindprint worked very efficiently and intuitively. It was very adept at understanding the complexities of our business processes and simplifying them in the context of developing an ERP system that suited our needs," said Dr. Janice Parente, President of ethica Clinical Research Inc. "Axpert has been successful at consolidating and centralizing ethica's key processes in a way that allows us to manage the business more effectively and efficiently."
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.